A House-Senate conference committee on Beacon Hill will soon make decisions about the health care industry in Massachusetts. While the focus of the committee’s work is cost containment, the outcome of those deliberations may have larger implications that could affect our state’s ability to compete in the international life sciences economy.
This concern comes to mind in the wake of the recent BIO Convention, which brought 15,000 biotechnology professionals from around the globe to Boston. Many visitors asked what led to the growth of the life sciences and biotechnology sector here and why so many of the leading life sciences companies decided to locate here.

Comments
I'm not clear about the comparison to the tech names of the past. Their demise was primarily attributed to their collective reluctance to depart from thier respective proprietary technical architecures and embrace open standards. In the case of DEC, it is very well known that the leadership there missed the boat entirely on the shift to micro-computing. Can the state pick winners? Probabaly not. What it can do is clarify regulations, simplify permiting, help drive down the cost of electricity that is so vital in bio/pharma research and manufacturing and fund research grants to name a few things. It can also do away with non-compete clauses in MA employmnet contracts. Some of the governor's proposals are on target. others not so much. But yes, government does have a role in bolstering our economic platform. However, it should perhaps focus on the legal, regulatory and educational aspects of that engine rather than attempting to make risky direct investments in companies.
I understand why those benefitting from the status quo in healthcare make demagogic analogies, but quite simply if healthcare cost are not addressed now, Massachusetts' companies of all types, new and old, will not be able to afford health insurance for their employees. This is a serious matter that Massachusetts must address ASAP. Future austerity should not be our only option. Louis Dusseault M.D.